Intellia Therapeutics (NTLA) EBIT Margin Growth (1y) (2016 - 2026)
Intellia Therapeutics (NTLA) EBIT Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Intellia Therapeutics |
1.86 Bn |
1.86 Bn |
- |
5,850.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
5,850.00 |
| Dec 31, 2025 |
63,101.00 |
| Sep 30, 2025 |
78,010.00 |
| Jun 30, 2025 |
122,643.00 |
| Mar 31, 2025 |
-33,257.00 |
| Dec 31, 2024 |
-835,731.00 |
| Sep 30, 2024 |
-49,567.00 |
| Jun 30, 2024 |
-102,513.00 |
| Mar 31, 2024 |
49,414.00 |
| Dec 31, 2023 |
810,852.00 |
| Sep 30, 2023 |
-29,779.00 |
| Jun 30, 2023 |
-27,282.00 |
| Mar 31, 2023 |
39,383.00 |
| Dec 31, 2022 |
-18,547.00 |
| Sep 30, 2022 |
2.32 Mn |
| Jun 30, 2022 |
35,305.00 |
| Mar 31, 2022 |
-56,163.00 |
| Dec 31, 2021 |
1,729.00 |
| Sep 30, 2021 |
-2.39 Mn |
| Jun 30, 2021 |
-85,057.00 |
